Tsokos GC - Search Results

1

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections.

Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L, Krishfield S, Malavasi F, Yoon J, Sui SJH, Kyttaris VC, Tsokos GC. Katsuyama E, et al. Among authors: tsokos gc. Cell Rep. 2020 Jan 7;30(1):112-123.e4. doi: 10.1016/j.celrep.2019.12.014. Cell Rep. 2020. PMID: 31914379 Free PMC article.

2

Uncovering the genetics of systemic lupus erythematosus: implications for therapy.

Kyttaris V, Tsokos G. Kyttaris V, et al. Am J Pharmacogenomics. 2003;3(3):193-202. doi: 10.2165/00129785-200303030-00005. Am J Pharmacogenomics. 2003. PMID: 12814327 Review.

3

Gene therapy in systemic lupus erythematosus.

Kyttaris VC, Juang YT, Tsokos GC. Kyttaris VC, et al. Among authors: tsokos gc. Lupus. 2004;13(5):353-8. doi: 10.1191/0961203304lu1026oa. Lupus. 2004. PMID: 15230292 Review.

4

T lymphocytes in systemic lupus erythematosus: an update.

Kyttaris VC, Tsokos GC. Kyttaris VC, et al. Among authors: tsokos gc. Curr Opin Rheumatol. 2004 Sep;16(5):548-52. doi: 10.1097/01.bor.0000132646.55056.e0. Curr Opin Rheumatol. 2004. PMID: 15314492 Review.

5

Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus.

Kyttaris VC, Juang YT, Tenbrock K, Weinstein A, Tsokos GC. Kyttaris VC, et al. Among authors: tsokos gc. J Immunol. 2004 Sep 1;173(5):3557-63. doi: 10.4049/jimmunol.173.5.3557. J Immunol. 2004. PMID: 15322221

6

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.

Juang YT, Wang Y, Solomou EE, Li Y, Mawrin C, Tenbrock K, Kyttaris VC, Tsokos GC. Juang YT, et al. Among authors: tsokos gc. J Clin Invest. 2005 Apr;115(4):996-1005. doi: 10.1172/JCI22854. J Clin Invest. 2005. PMID: 15841182 Free PMC article.

7

Immune cells and cytokines in systemic lupus erythematosus: an update.

Kyttaris VC, Juang YT, Tsokos GC. Kyttaris VC, et al. Among authors: tsokos gc. Curr Opin Rheumatol. 2005 Sep;17(5):518-22. doi: 10.1097/01.bor.0000170479.01451.ab. Curr Opin Rheumatol. 2005. PMID: 16093827 Review.

8

Increased caspase-3 expression and activity contribute to reduced CD3zeta expression in systemic lupus erythematosus T cells.

Krishnan S, Kiang JG, Fisher CU, Nambiar MP, Nguyen HT, Kyttaris VC, Chowdhury B, Rus V, Tsokos GC. Krishnan S, et al. Among authors: tsokos gc. J Immunol. 2005 Sep 1;175(5):3417-23. doi: 10.4049/jimmunol.175.5.3417. J Immunol. 2005. PMID: 16116236

9

Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC. Katsiari CG, et al. Among authors: tsokos gc. J Clin Invest. 2005 Nov;115(11):3193-204. doi: 10.1172/JCI24895. Epub 2005 Oct 13. J Clin Invest. 2005. PMID: 16224536 Free PMC article.

10

The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain.

Tenbrock K, Kyttaris VC, Ahlmann M, Ehrchen JM, Tolnay M, Melkonyan H, Mawrin C, Roth J, Sorg C, Juang YT, Tsokos GC. Tenbrock K, et al. Among authors: tsokos gc. J Immunol. 2005 Nov 1;175(9):5975-80. doi: 10.4049/jimmunol.175.9.5975. J Immunol. 2005. PMID: 16237091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

621 results

Search Page